Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Pfizer CT.gov Call Center
Pfizer
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
316 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chris O'Brien Lifehouse
Camperdown, New South Wales, Australia
- Chris O'Brien Lifehouse Medical Imaging
Camperdown, New South Wales, Australia
- Chris O'Brien Lifehouse Radiation Oncology Department
Camperdown, New South Wales, Australia
- Northern Sydney Cancer Centre
St Leonards, New South Wales, Australia
- Illawarra Shoalhaven Local Health District
Wollongong, New South Wales, Australia
- Barwon Health, University Hospital Geelong
Geelong, Victoria, Australia
- Austin Health
Heidelberg, Victoria, Australia
- Ordensklinikum Linz Gmbh
Linz, Austria
- University Hospital Brussels
Brussels, Belgium
- Grand Hopital de Charleroi - Site Notre-Dame
Charleroi, Belgium
- Centre Hospitalier de Jolimont
Haine-Saint-Paul, Belgium
- Site Sainte Elisabeth / Chu Ucl Namur
Namur, Belgium
- Gza Hospitals Campus Sint Augustinus
Wilrijk, Belgium
- Chu de Quebec - Universite Laval
Québec, Quebec, Canada
- Beijing Cancer Hospital
Beijing, Beijing Municipality, China
- Fujian Cancer Hospital
Fuzhou, Fujian, China
- Cancer Center of Guangzhou Medical University/oncology Department
Guangzhou, Guangdong, China
- Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
- Affiliated Tumor Hospital of Guangxi Medical University
Nanning, Guangxi, China
- Hai Nan General Hospital
Haikou, Hainan, China
- Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
- Henan Cancer Hospital
Zhengzhou, Henan, China
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology/cancer Center
Wuhan, Hubei, China
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
- Xiangya Hospital Central South University/oncology Department
Changsha, Hunan, China
- Liaoning Cancer Hospital & Institute
Shenyang, Liaoning, China
- Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
- Shanghai East Hospital/oncology Department
Shanghai, Shanghai Municipality, China
- West China Hospital of Sichuan University
Chengdu, Sichuan, China
- Tianjin Cancer Hospital
Tianjin, Tianjin Municipality, China
- Institut de Cancerologie de L'Ouest (ico) - Site Paul Papin
Angers, France
- Institut Sainte Catherine
Avignon, France
- Hopital Pellegrin - Service de Radiologie Et D'Imagerie
Bordeaux, France
- Hopital Saint-Andre
Bordeaux, France
- Cabinet de Radiologie Privé - Dr Joseph Mocaer
Brest, France
- Clinique Pasteur - Cfro
Brest, France
- Hopital Franco-Britannique, Institut D'Oncologie Hauts-de-Seine Nord
Levallois-Perret, France
- Institut Regional Du Cancer Montpellier - Val D'Aurelle
Montpellier, France
- Hopital Prive Du Confluent S.A.S
Nantes, France
- Hopital Prive Du Confluent S.A.S.
Nantes, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Nov 2016
- Primary completion
- 23 Dec 2019
- Completion
- 25 Aug 2020
- Last update posted
- 22 Sept 2021
- Registered enrollment
- 697
- Registry id
- NCT02952586
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.